What is the clinical and economic burden associated with new cardiovascular events among patients with hyperlipidemia?
New cardiovascular events in hyperlipidemic patients are associated with significantly increased healthcare utilization and costs that persist for at least 3 years.
Among hyperlipidemic patients with new CVE, healthcare utilization and costs incurred were significantly higher than for those without CVE during the acute phase, and remained higher up to 3 years post-event, across all risk cohorts.
Fox et al. (Thu,) studied this question.